13th Nov 2026 10:47
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.
----------
FTSE 100 WINNERS
----------
Aviva PLC, up 2.7% at 759.20 pence, on track to hit targets amid General Insurance and Wealth growth
----------
Centrica PLC, up 1.9% at 157.675p
----------
Admiral Group PLC, up 1.2% at 3,974.00p
----------
Shell PLC, up 1.2% at 3,708.25p
----------
Associated British Foods PLC, up 1.2% at 2,029.00p
----------
FTSE 100 LOSERS
----------
3i Group PLC, down 2.1% at 2,653.00p, Citi cuts price target to 3,700p from 4,040p
----------
Vodafone Group PLC, down 1.8% at 115.95p
----------
Weir PLC, down 1.6% at 2,350.00p
----------
WPP Group PLC, down 1.4% at 414.30p
----------
Babcock International Group PLC, down 1.4% at 981.80p
----------
FTSE 250 WINNERS
----------
Asos PLC, up 2.2% at 472.75 pence, Peel Hunt upgrades rating to 'buy', sets price target to 560p
----------
B&M European Value Retail PLC, up 2.1% at 344.60p
----------
GlobalData PLC, up 1.7% at 66.60p
----------
Lancashire Holdings Ltd, up 1.6% at 656.50p
----------
Partners Group Private Equity Ltd, up 1.5% at EUR6.86
----------
FTSE 250 LOSERS
----------
WH Smith PLC, down 7.7% at 367.80p, stock extends losses after annual results on Thursday
----------
Qinetiq Group PLC, down 4.9% at 475.50p, stock continues to slide after announcement of sale of US business to Serco on Thursday
----------
Young & Co's Brewery PLC, down 3.5% at 1,063.00p, stock continues to fall after interim results on Thursday held dividend and guidance
----------
Oxford BioMedica PLC, down 2.9% at 519.50p, Jefferies cuts price target to 716p from 827p
----------
Chemring Group PLC, down 2.7% at 496.20p; says on Thursday it aims to sell its US sensors business
----------
FTSE 100 & 250 movers in focus:
----------
Aviva PLC, up 2.7% at 759.20 pence, 12-month range 590.60p-763.80p. The insurer and asset manager reports an 18% increase in general insurance premiums to GBP11.80 billion in the first nine months of 2026 from GBP9.97 billion a year earlier, driven by growth in UK personal lines following its acquisition of Direct Line Insurance Group. UK general insurance premiums rise 28% to GBP8.02 billion from GBP6.27 billion, while premiums in Ireland increase 9.0% and Canada premiums edge up 1.2%. The group's undiscounted combined operating ratio improves to 93.8% from 94.4%, while Wealth net flows grow 31% to GBP10.87 billion from GBP8.31 billion. Retirement new business sales fall 34% to GBP3.50 billion from GBP5.33 billion, reflecting a 50% decline in bulk purchase annuity sales. Aviva reiterates its three-year financial targets, including 11% compound annual growth in operating earnings per share between 2025 and 2028, return on equity above 20% by 2028 and cash remittances exceeding GBP7 billion between 2026 and 2028. It continues to expect operating EPS growth in 2026 broadly in line with its 11% target and forecasts its solvency II shareholder cover ratio to reach the high-180s by year-end, from an estimated 179% currently. Chief Executive Amanda Blanc says Aviva is in "great shape", citing strong, profitable growth in General Insurance and Wealth, and expresses confidence in meeting its three-year financial targets.
----------
GSK PLC, up 0.7% at 1,913.00 pence, 12-month range 1,690.00p-2,282.00p. Says the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanding the label of its Bexsero meningitis B vaccine to include a single booster dose for people aged 10 and older who received their initial vaccination at least two years earlier. The recommendation is supported by data from a phase IIIb trial, which met its primary endpoint and showed that immune memory established through vaccination in infancy can be boosted up to 19 years later. GSK says the booster could help maintain protection into adolescence, when meningococcal disease incidence reaches a second peak.
----------
Land Securities Group PLC, up 0.9% at 702.00 pence, 12-month range 525.00p-726.00p. Reports a rise in pretax profit to GBP243 million for the six months to September 30 from GBP98 million a year earlier, supported by a GBP88 million property valuation surplus. EPRA earnings remain flat at GBP192 million, while EPRA earnings per share edge up to 25.9 pence from 25.8p. Like-for-like net rental income grows 6.2%, and the interim dividend rises 2.1% to 19.4p per share. The property developer now expects full-year like-for-like rental income growth at the upper end of its 3% to 5% guidance range and forecasts improved high-single-digit EPRA EPS growth in financial 2028.
----------
By Eva Castanedo, Alliance News senior economics reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
AvivaCentricaAdmiralShellAB Foods3i GroupVodafoneWeir GroupWPPBabcockASOSB&MGlobalDataLancashire HoldingsPartners Grp EWh SmithQinetiqYoung & Co's BreweryOxford BiomedicaChemringLand Securities